fda approvals in cinv and her2 breast cancer, priority review in myelofibrosis, and more
Published 5 years ago • 141 plays • Length 10:55
Download video MP4
Download video MP3
Similar videos
-
11:00
fda approval in her2 breast cancer, priority review in nsclc, and more
-
9:37
fda approvals in nhl and cinv, priority reviews in melanoma and breast cancer, and more
-
9:29
fda approvals in all and breast cancer, priority reviews in cml and follicular lymphoma, and more
-
10:46
fda approval in all, priority reviews in cml and breast cancer, and more
-
7:28
fda approvals in pml, nsclc, and breast cancer, priority review in dlbcl, and more
-
7:18
full fda approvals in breast cancer and lung cancer, priority reviews in all, and more
-
0:31
onn preview: priority review in ovarian cancer, mixed results in myelofibrosis, and more
-
4:37
cancer advance of the year, fda approval for cinv, breakthrough designation in tnbc, and more
-
7:21
fda approval in breast cancer, breakthrough designations in aml and bladder cancer, and more
-
11:13
fda approval in her2 early breast cancer, fast track designation in tnbc, and more
-
5:18
fda approval in cinv, new asco guideline for dcis, promising findings in aml, and more
-
10:00
fda approval in breast cancer, review period extended in aml, 2019 aacr highlights, and more
-
6:48
fda approval in prostate cancer, phase iii data in breast cancer, and more
-
8:51
fda approvals in nets, breast cancer, aml, a biosimilar, and more
-
0:43
dr. hamilton on fda approval of adjuvant pertuzumab regimen in her2 early breast cancer
-
9:27
fda approval in bladder cancer, breakthrough therapy designation in dlbcl, and more
-
6:44
fda approval in rare leukemias, priority reviews in msi-h cancers and mcc, and more
-
1:00
dr. hurvitz on fda approval of subcutaneous trastuzumab formulation in her2 breast cancer
-
9:02
fda approval in sarcoma, priority reviews in mcrpc and myeloma, and more
Clip.africa.com - Privacy-policy